Clinical Trial Update: Cetuximab in Treating Patients With Stage IV Colorectal Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update showing that cetuximab for stage IV colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED